PredictionBook transitioning to read-only mode at the end of 2023 ( read more ).

One or more current SSRI or SNRI (includes newer generation serotonergics like Viibrid) becomes under investigation by FDA for misrepresentation of clinical trial results before 2020.

Created by jesselevine on 2016-02-22; known on 2020-01-01; judged wrong by Tapetum-Lucidum on 2020-04-21.

Please log in to respond to or judge prediction